FDA Approves COLCHICINE — Micro Labs Limited

# FDA Approves Colchicine Generic From Micro Labs Limited Micro Labs Limited received FDA approval for its generic colchicine oral formulation, expanding the competitive landscape in the acute gout and familial Mediterranean fever treatment market and potentially driving down drug costs for patients relying on this established therapeutic. The approval adds another generic competitor to the colchicine market, which could further pressure pricing and market share among existing branded and generic manufacturers.